Literature DB >> 2614794

Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias.

P W Lunt1, D A Compston, P S Harper.   

Abstract

In any family study using information gathered retrospectively, the influence of the method of ascertainment on the observed segregation ratio in sibships needs careful consideration. The study of kindred members from outside the area of primary ascertainment is invaluable in providing segregation data with minimal ascertainment bias. For facioscapulohumeral muscular dystrophy (FSHD), using this approach, and based on the presence or absence of characteristic clinical signs rather than on an historical account of age at onset, estimates were derived for penetrance of the FSHD gene of less than 5% for ages 0 to 4 years, 21% for ages 5 to 9, 58% for ages 10 to 14, 86% for ages 15 to 19, and 95% penetrance for age 20 years and over. No difference between families was identified. These figures should facilitate genetic counselling and the interpretation of genetic linkage study results in FSHD.

Entities:  

Mesh:

Year:  1989        PMID: 2614794      PMCID: PMC1015755          DOI: 10.1136/jmg.26.12.755

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Discrimination of genetic entities in muscular dystrophy.

Authors:  C S CHUNG; N E MORTON
Journal:  Am J Hum Genet       Date:  1959-12       Impact factor: 11.025

2.  Studies in disorders of muscle. II Clinical manifestations and inheritance of facioscapulohumeral dystrophy in a large family.

Authors:  F H TYLER; F E STEPHENS
Journal:  Ann Intern Med       Date:  1950-04       Impact factor: 25.391

3.  A pedigree of hereditary progressive muscular dystrophy.

Authors:  J W BOYES; F C FRASER
Journal:  Ann Eugen       Date:  1949-10

4.  DNA probes in differential diagnosis of Becker muscular dystrophy and spinal muscular atrophy.

Authors:  P W Lunt; W J Cumming; H Kingston; A P Read; R C Mountford; M Mahon; R Harris
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

5.  Infantile facioscapulohumeral muscular dystrophy: new observations.

Authors:  R O Bailey; D C Marzulo; M B Hans
Journal:  Acta Neurol Scand       Date:  1986-07       Impact factor: 3.209

6.  Genetic-epidemiological studies in progressive muscular dystrophy.

Authors:  J Prot
Journal:  J Med Genet       Date:  1971-03       Impact factor: 6.318

7.  The use of life tables and survival analysis in testing genetic hypotheses, with an application to Alzheimer's disease.

Authors:  G A Chase; M F Folstein; J C Breitner; T H Beaty; S G Self
Journal:  Am J Epidemiol       Date:  1983-05       Impact factor: 4.897

Review 8.  Clinical features and classification of the muscular dystrophies.

Authors:  D Gardner-Medwin
Journal:  Br Med Bull       Date:  1980-05       Impact factor: 4.291

9.  Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications.

Authors:  R B Fitzsimons; E B Gurwin; A C Bird
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

Review 10.  Modern methods of diagnosis of muscle diseases.

Authors:  R H Edwards; R D Griffiths; M Hayward; T Helliwell
Journal:  J R Coll Physicians Lond       Date:  1986-01
  10 in total
  28 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  The mapping of chromosome 4q markers in relation to facioscapulohumeral muscular dystrophy (FSHD).

Authors:  M Upadhyaya; P Lunt; M Sarfarazi; W Broadhead; J Farnham; P S Harper
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

3.  Linkage localization of facioscapulohumeral muscular dystrophy (FSHD) in 4q35.

Authors:  K D Mathews; K A Mills; E P Bosch; V V Ionasescu; K R Wiles; K H Buetow; J C Murray
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q.

Authors:  M Upadhyaya; P W Lunt; M Sarfarazi; W Broadhead; J Daniels; M Owen; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

5.  A clinically homogeneous group of families with facioscapulohumeral (Landouzy-Déjérine) muscular dystrophy: linkage analysis of six autosomes.

Authors:  S J Jacobsen; E S Diala; B V Dorsey; M B Rising; R Graveline; K Falls; P Schultz; C Hogan; K Rediker; C D'Amico
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

6.  New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?

Authors:  Mouna Barat-Houari; Karine Nguyen; Rafaëlle Bernard; Céline Fernandez; Catherine Vovan; Corinne Bareil; Philippe Khau Van Kien; Delphine Thorel; Sylvie Tuffery-Giraud; Francis Vasseur; Shahram Attarian; Jean Pouget; Anne Girardet; Nicolas Lévy; Mireille Claustres
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

7.  Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression.

Authors:  R Tupler; L Barbierato; M Memmi; C A Sewry; D De Grandis; P Maraschio; L Tiepolo; A Ferlini
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

8.  Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases.

Authors:  E Bakker; M J Van der Wielen; E Voorhoeve; P F Ippel; G W Padberg; R R Frants; C Wijmenga
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  A radiation hybrid map of 15 loci on the distal long arm of chromosome 4, the region containing the gene responsible for facioscapulohumeral muscular dystrophy (FSHD).

Authors:  S T Winokur; B Schutte; B Weiffenbach; S S Washington; D McElligott; A Chakravarti; J H Wasmuth; M R Altherr
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

10.  De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1).

Authors:  P E Jardine; M C Koch; P W Lunt; J Maynard; K D Bathke; P S Harper; M Upadhyaya
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.